Blood Glucose Control

Real-time monitoring produces significant long-term improvement in HbA1c.

With fewer side effects, much less expensive drugs still found to be effective.

Treatment of hypoglycemia contributes to ASCVD risk reduction.

T1D patients with certain characteristics would benefit the most from reimbursement of blood glucose test strips.

Once the patient is educated, they should be allowed to take charge of their care.

Beta-blocker use in patients with T2DM and established CV risk factors associated with increased risk of CV events and severe hypoglycemia, according to recent study.

Combination ANRI sacubitril/valsartan (EntrestoR) showed significant reduction in risk for cardiovascular death and hospitalization for worsening heart failure.

Studies show that half of Chinese adults have an increased risk for prediabetes and diabetes; Tibetan and Muslim Chinese at lowest risk.

People with type 1 diabetes receiving once-daily injection of glucagon-blocking drug, REMD-477 can reduce their insulin use considerably and improve blood glucose levels without altering hypoglycemia.

The value of self-monitoring of blood glucose (SMBG) levels in patients with non-insulin-treated type 2 diabetes has been debated over the years.